Sep 26, 2024 / 08:30AM GMT
Presentation
Sep 26, 2024 / 08:30AM GMT
=====================
Corporate Participants
=====================
* Sarah Howell
Arecor Therapeutics PLC - Chief Executive Officer, Executive Director
=====================
Conference Call Participants
=====================
* Julie Simmonds
Panmure Liberum - Analyst
* Carl Cager
Singer Capital Markets - Analyst
* Christian Glennie
Stifel Nicolaus Europe Limited - Analyst
=====================
Sarah Howell - Arecor Therapeutics PLC - Chief Executive Officer, Executive Director
Thanks. Good morning, everybody. It's a pleasure to be here. And so I see so many people in the room and welcome to those joining today online. So as you know, my name's Sarah Howell. I'm the CEO of Arecor Therapeutics. And we're here today to talk through our interim results for the six months ending June 30, 2024.
So I'll draw your attention, as usual, to our customary legal notice. So I know, certainly, everybody in the room today knows the company pretty well
Half Year 2024 Arecor Therapeutics PLC Earnings Presentation Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot